117 related articles for article (PubMed ID: 17825596)
1. [Alternative approaches to ovarian stimulation].
Alvarez S
Gynecol Obstet Fertil; 2007 Sep; 35(9):885-9. PubMed ID: 17825596
[TBL] [Abstract][Full Text] [Related]
2. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
[TBL] [Abstract][Full Text] [Related]
3. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
4. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
9. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
10. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
11. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.
Kim CH; Jeon GH; Cheon YP; Jeon I; Kim SH; Chae HD; Kang BM
Fertil Steril; 2009 Nov; 92(5):1758-60. PubMed ID: 19523618
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of agonists versus antagonists for i.v.f. stimulation: the French FIVNAT survey 2001-2002].
Pouly JL; Bachelot A; de Mouzon J; Devaux A;
Gynecol Obstet Fertil; 2004 Sep; 32(9):737-40. PubMed ID: 15380755
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonists vs antagonists.
Tarlatzis BC; Kolibianakis EM
Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
[TBL] [Abstract][Full Text] [Related]
15. Mild ovarian stimulation for IVF: 10 years later.
Fauser BC; Nargund G; Andersen AN; Norman R; Tarlatzis B; Boivin J; Ledger W
Hum Reprod; 2010 Nov; 25(11):2678-84. PubMed ID: 20858698
[TBL] [Abstract][Full Text] [Related]
16. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
17. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
[TBL] [Abstract][Full Text] [Related]
18. Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
Manno M; Tomei F; Cervi M; Favretti C; Adamo V
Fertil Steril; 2009 Apr; 91(4 Suppl):1431-3. PubMed ID: 18706554
[TBL] [Abstract][Full Text] [Related]
19. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
20. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
